Advances in Neuroscience and Technology: The Future of Neurorehabilitation

1.5 CE Credit


Presented by:
Alison N. Cernich, Ph.D., ABPP-Cn
Director, National Center for Medical Rehabilitation Research
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institutes of Health







A fundamental shift is occurring in neuroscience, particularly in the study of human brain function, due to advances in methodology, technology, and neuroimaging. Advances in the understanding of brain circuitry and signaling, and the resultant impact on the assessment of function, are moving rapidly due to a major investment in these areas through the National Institute of Health’s (NIH) BRAIN initiative and other funded studies by the NIH. Imaging modalities, including those that now allow for imaging during free living activity, are changing the capacity of scientists to understand the relationships between brain activity and function. In addition, interventions for individuals with dense paralysis, profound communication impairment, and limb loss are advancing rapidly due to the increasing use of brain-machine interfaces that were previously considered the realm of science fiction. NIH continues to invest in novel neuropsychological assessment methods that can be administered via computer technologies, gamified cognitive testing to increase engagement and assess multiple domains of function simultaneously, and virtual reality treatments to impact real-world function. The presenter will provide an overview of potential implications for the field of neuropsychology and neurorehabilitation secondary to these advances, and perspectives on where the field should be poised during this time of transition. In addition, resources for funding and training in these methodologic advances will be provided.

After the session, participants will be able to:

1.     Discuss the purpose of the NIH’s BRAIN initiative and  how the studies funded by this initiative  will impact the field of neuropsychology.
2. Summarize new approaches to imaging that are yielding new types of information on brain integrity and brain function.
3. Describe new applications of brain-machine interfaces and their impact on function for individuals with severe impairments due to brain or spinal cord injury or acquired brain conditions.
4. Explain new approaches to cognitive assessment through the use of technology that will transform the field of neuropsychology.

Target Audience:
Neuropsychologists across the career span.
Instructional Level: Introduction 

Alison Cernich, Ph.D., serves as the Director of the National Center for Medical Rehabilitation Research (NCMRR) at the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. She provides oversight for the portfolio of NCMRR and works within NIH to coordinate rehabilitation research. She serves on multiple interagency strategic planning committees and government oversight committees for major research initiatives in the federal government relevant to disability and rehabilitation research.

NAN members login and non-members create an account to:



Neuroimaging for Neuropsychologists

1.5 CE Credits

Presented by:
Erin Bigler, Ph.D.
 
Some form of brain imaging is routinely performed on most patients that are seen by neuropsychologists.  Neuroimaging is considered a foundation area of study and training for neuropsychologists. This webinar will cover the common neuroimaging modalities of computed tomography (CT), magnetic resonance imaging (MRI), single photon emission computed tomography (SPECT) and positron emission tomography (PET) and their relevance to clinical neuropsychology. The basis for understanding neuroimaging begins with neuroanatomy and neuropathology, which will be covered.  Anatomical identification across the different imaging modalities will be overviewed followed by a very practical approach showing how neuroimaging findings may be integrated with neuropsychological assessment. Neuroimaging findings in common disorders as seen by neuropsychologists such as traumatic brain injury, stroke, multiple sclerosis, neurodevelopmental disorders, aging and neurodegenerative disease will be highlighted. Methods of quantitative neuroimaging, especially automated techniques like FreeSurfer will be overviewed. The webinar will conclude with a discussion of the role of advanced neuroimaging techniques like functional MRI (fMRI) and the development of standardized cognitive probes, use of fMRI techniques in assessing resting state functional connectivity mapping combined with diffusion tensor imaging (DTI) that permit assessment of network functioning in neuropsychology.

After the webinar, participants will be able to:

  1. Describe the differences in technology that generate computed tomographic (CT) scans, magnetic resonance imaging (MRI) scans and radiotracer-based tomography [single photon emission computed tomography  (SPECT) or positron emission tomography (PET).
  2. Assess basic neuroanatomy from viewing CT, MRI, SPECT and/or PET imaging studies.
  3. Explain the basics of neuropathological findings from viewing CT, MRI, SPECT and/or PET imaging studies.
  4. Apply neuroimaging decision making skills relevant to integrating scan findings with neuropsychological assessment and cognitive/neurobehavioral outcome in disorders like traumatic brain injury, stroke, demyelinating disorders, developmental syndromes, ageing and degenerative diseases. 

Target Audience:Clinical neuropsychologists or Ph.D. students in training

Instructional Level:(Intermediate-to-Advanced) The presentation will assume some formal prior training in neuroanatomy and pathoanatomical correlates for the major neurological and neuropsychiatric disorders

About Erin Bigler, Ph.D.
Erin D. Bigler, Ph.D. holds the Susa Young Gates Chair as Professor of Psychology and Neuroscience at Brigham Young University (BYU) where he served as Chair of the Psychology Department for over six years (1996-2002). He is also an Adjunct Professor in the Department of Psychiatry at the University of Utah. He was formerly a professor of psychology and psychiatry at the University of Texas, until he returned to Utah in 1990 to assume his current position. In 1977 at the University of Texas at Austin he established the clinical neuropsychology subspecialty training program that continues to this day and in the early 1980’s at Austin also established the Brain Imaging and Behavior Laboratory, which he brought with him when he came to BYU. The Brain Imaging and Behavior Laboratory has played a key role in numerous multisite collaborative studies providing quantitative neuroimaging analysis. His research has focused on the interface between neuroimaging findings and methods of analysis in the study of cognitive and neurobehavioral outcome associated with a variety of disorders including traumatic brain injury, Alzheimer’s disease and related neurodegenerative disorders and neurodevelopmental disorders like autism and learning disability.  He served as President of the National Academy of Neuropsychology from 1989-1990 and later in 1999, received their Distinguished Clinical Neuropsychologist Award. In that same year, he was also the recipient of the Karl G. Maeser Distinguished Faculty Lecturer Award, Brigham Young University's top faculty honor.

Dr. Bigler has authored and developed several neuropsychological tests, published 90 book chapters, and authored and/or edited 9 textbooks—most recently as one of the coauthors of Muriel Lezak’s Neuropsychological Assessment – 5th  Edition.  He has also authored/co-authored and published over 270 peer-reviewed articles in neuropsychology, neuroimaging and cognitive neuroscience. 

Currently, Dr. Bigler is the President of the International Neuropsychological Society (INS) where he previously served as Treasurer and a member of the Board of Directors for many years. He was the inaugural Associate Editor for the Journal of the International Neuropsychological Society (JINS) and served in that capacity for 11 years.  He is the founding Associate Editor of the journal Brain Imaging and Behavior and likewise serves as an Associate Editor for Neuropsychology along with several other editorial boards.  He has been a licensed psychologist since 1975, practicing in the area of clinical neuropsychology, and holds a Diplomate from the American Board of Professional Psychology with special competence in clinical neuropsychology. He has trained over 125 doctoral students in his nearly 40 years as a professor.  Recently, Dr. Bigler was appointed the Director of BYU’s new MRI Research Facility which houses an on-campus Siemens 3Tesla magnetic resonance scanner.

NAN members login and non-members create an account to:

 

Neuropsychology Practice above the 49th Parallel

1.5 CE Credits



  Darcy Cox, Psy.D.
Private Clinical and Forensic Neuropsychology Practice
British Columbia and California 

   
 
Laura Janzen, Ph.D.
The Hospital for Sick Children, Toronto, ON


This course offers an introductory review of issues specific to neuropsychological practice in Canada, covering the basics of the Canadian health care system, Canadian demographics, and challenges specific to neuropsychological practice within the Canadian context.  It is intended to provide practical information relevant to neuropsychology trainees and practitioners who may be interested in moving to Canada or collaborating with Canadian neuropsychologists.  The webinar will not address specific immigration or work visa issues.

After the webinar, participants will be able to:

  1. Recognize and discuss important differences in professional training, licensure, and practice patterns between the United States and Canada.
  2. Describe how cultural and linguistic factors specific to Canada impact the administration and interpretation of neuropsychological tests.
  3. Explain transferability of neuropsychology training and practice between the United States and Canada.  

Target Audience: Students and neuropsychologists practicing in the United States and other countries who would like to learn more about the practice environment for neuropsychologists practicing in Canada.

Instructional Level: Introductory

Dr. Darcy Cox is a board-certified neuropsychologist practicing in Vancouver, British Columbia and a dual citizen of the United States and Canada.  Dr. Cox earned her Doctorate in Psychology from the Virginia Consortium Program in Clinical Psychology in 1999. She completed her clinical internship at the San Francisco Veterans Administration Medical Center and a National Multiple Sclerosis Society fellowship at the University of California, San Francisco. After her fellowship, Dr. Cox began a faculty position in the Department of Neurology at the University of California, San Francisco and in 2003, she opened a private practice in San Francisco specializing in clinical and forensic neuropsychological evaluations. In 2008, Dr. Cox immigrated to Vancouver, British Columbia.  She has worked as a neuropsychologist at Vancouver General Hospital in the Geriatric Psychiatry Outreach Team program and as a Senior Psychology Advisor through WorkSafeBC while maintaining a small forensic practice.  She is now in full-time private practice as a forensic neuropsychologist and a neuropsychological consultant.  

Dr. Laura Janzen is a board-certified neuropsychologist (subspecialist in pediatric neuropsychology) practicing in Toronto, Ontario. Dr. Janzen earned her Doctorate in Psychology from the University of Victoria in Clinical Psychology (Emphasis in Clinical Neuropsychology) in 2001.  Following pre-doctoral internship training at the London Health Sciences Center in London, Ontario, Dr. Janzen moved to the United States to complete a post-doctoral fellowship in neuropsychology at the University of Rochester Medical Center in Rochester, NY.  She then returned to Canada and has worked in hospital and rehabilitation settings.  She is currently employed at the Hospital for Sick Children, engaged in clinical work, research and training.


NAN members login and non-members create an account to:

New Frontiers in Brain Stimulation

1.5 CE Credits

Presented by:
Frank MacMaster, Ph.D.
Alberta Children's Hospital
Associate Professor, Psychiatry and Pediatrics, Cumming School of Medicine, University of Calgary


 





Noninvasive Brain Stimulation (or NiBS) methods include Transcranial Direct Current Stimulation and Transcranial Magnetic Stimulation. Over the past decade, both of these methods have experienced explosive growth in their application both to understand the human brain and to treat neuropsychiatric disorders. In this course, we will discuss NiBS and its application in youth. First, we will explain the types of NiBS currently in use, and their potential risks and benefits. Second, we will address their use as a probe of brain function. Third, we will explore their application in neuropsychiatric disorders in youth.

After the webinar, participants will be able to: 
1. Explain the types of NiBS currently in use, and list their potential risks and benefits. 
2. Discuss the use of NiBS methods as a probe of brain function. 
3. Describe the application of NiBS methods in neuropsychiatric disorders in youth.

Target Audience: Neuropsychologists who work with children and adolescents in clinical settings from hospitals to schools.
Instructional Level: Intermediate

Frank MacMaster 
is an Associate Professor in the Departments of Psychiatry and Paediatrics, University of Calgary. He is also the Scientific for the Addictions and Mental Health Strategic Clinical Network in Alberta Health Services. 

He received his bachelors in psychology for Saint Mary's University, completed doctoral work at Dalhousie University in neurobiology, and a postdoctoral fellowship in brain imaging in child psychiatry at Wayne State University. Dr. MacMaster has received funding from NARSAD, the Canadian Institute for Health Research, Canadian Foundation for Innovation, among other honors. 

He has over 88 peer-reviewed papers and has been cited over 3700 times. His work is focused on using neuroimaging methods to better understand the underlying neurobiology and impact of novel interventions like neurostimulation in child and adolescent mental health.

NAN members login and non-members create an account to:

Providing Effective Neuropsychological Supervision

1.5 CE Credits

Presented by:
Bernice Marcopulos, Ph.D.
Associate Professor
Department of Graduate Psychology
James Madison University

As clinical neuropsychologists, many, if not most of us regularly supervise trainees, but do we really know what we are doing? Supervision is seldom taught in graduate school and according to Stucky, Bush & Donders (2010) “it is the extremely rare neuropsychology conference that offers a continuing education workshop on neuropsychological supervision.” (p. 741).  This workshop is intended to address this deficiency and provide an opportunity to reflect upon what makes a good clinical neuropsychology supervisor. This workshop will draw on material from Stucky, et al. (2010) and Fouad et al (2009) to provide a conceptual and structural framework for providing effective supervision in clinical neuropsychology. Participants will review methods for developing and measuring training goals from a developmental perspective (practicum, internship, post-doctoral fellowship). 

After the webinar, participants will be able to:

  1. Utilize foundational and functional competencies in professional psychology as a basis for supervision of trainees in clinical neuropsychology.
  2. List achievable goals of supervision for each level of training (practicum, internship, post-doctoral fellowship) in neuropsychology
  3. Explain how the APA Ethics code and organizational guidelines (NAN, AACN) relate to clinical supervision in neuropsychology
  4. Describe methods for measuring training goals and efficacy of supervision. 

Target Audience:Clinical neuropsychologists involved in supervising practicum students, pre-doctoral interns and postdoctoral fellows in patient care settings

Instructional Level:(Intermediate-to-Advanced) Intermediate

About Bernice A. Marcopulos, Ph.D., ABPP 
Bernice A. Marcopulos, Ph.D., ABPP received her B.A. (High Honors) from the University of Florida and her Ph.D. from the University of Victoria in British Columbia, Canada.  She is Board Certified in Clinical Neuropsychology from the American Board of Professional Psychology. Currently she is Associate Professor of Graduate Psychology at James Madison University in Harrisonburg, VA and Associate Professor of Psychiatry and Neurobehavioral Sciences at the University of Virginia (UVA) Health Sciences Center in Charlottesville, VA. Dr. Marcopulos was the Director of the Western State Hospital (WSH) Neuropsychology Laboratory in Staunton, Virginia for 20 years where she co-Directed (with Drs. Jeff Barth and Donna Broshek) the UVA/WSH post-doctoral fellowship in Clinical Neuropsychology, an Association of Post-Doctoral Programs in Clinical Neuropsychology member program.  She taught assessment in the Department of Psychology at UVA and supervised interns, practicum students and post-doctoral fellows. Her research and clinical interests include the effects of education and culture on neuropsychological testing, dementia, schizophrenia, and criminal forensic issues. She is the co-editor of Clinical Neuropsychological Foundations of Schizophrenia (2012).  She was a Fulbright Fellow in the Psychology Department at the University of Warsaw in 1994 and was elected as a Fellow in NAN and APA. She was recently on the APA Committee for Psychological Tests and Assessment and is a consulting editor for The Clinical Neuropsychologist. She has served as a Board Member and Oral Examiner for the American Board of Clinical Neuropsychology, and she currently chairs the Examination Committee of the ABCN.  Dr. Marcopulos is serving her second term as Secretary of the International Neuropsychological Society.

NAN members login and non-members create an account to:

1.75 CE Credit

 

Presented by:
Kenneth Podell, Ph.D., FACPN
John M. O’Quinn Centennial Clinical Academic Scholar in Concussion Research and Care
Director, The Houston Methodist Concussion Center & Neuropsychology Section








 

C. Munro Cullum, Ph.D., ABPP-CN
The University of Texas Southwestern Medical Center








Gerard A Gioia, PhD
Division Chief, Pediatric Neuropsychology, Children’s National Medical Center

 





The practice of neuropsychology has traditionally been conducted in an office, clinic, or hospital setting with the patient/client present. New models of service are being introduced that open new doors to our profession. Telehealth is revolutionizing health care and becoming a mainstream mode of clinical delivery. Telehealth has the unique ability to connect healthcare providers with patients across town as well as around the world, decrease cost and expand access to high-quality specialty care, and improve patient compliance and satisfaction.  The goal of this panel discussion is to introduce several neuropsychological applications of telehealth. The panel will present and discuss: the history of telehealth in psychology and neuropsychology (aka “telepsychology”); the current technology available for clinical practice; the evidence to support test administration via videoconference in cognitive disorders of aging and sports neuropsychology settings; specifics about state and national laws and insurance and billing issues; and its potential role and limitations in home-based assessments.

 After the webinar, participants will be able to:

1. Outline the history and definition of telepsychology and discuss its clinical and research applications.
2. Describe state laws governing the use of telepsychology in clinical practice along with PSYPACT, Medicare regulations, and ethical guidelines for its use.
3. Discuss the literature and identify reliable and valid measures for video conference-administered assessment.
4. Describe home-based cognitive assessment and discuss its potential to facilitate care as well as its dangers and limitations.

 

Target Audience: Clinicians who are interested in the practical, ethical, and legal considerations when broaching online therapy and assessment services.

Instructional Level: Introductory 

Dr. Podell is the John M. O’Quinn Centennial Clinical Academic Scholar in Concussion Research and Care and the Director of The Houston Methodist Concussion Center and Neuropsychology Section, Dept. of Neurology, Houston Methodist. and is an Associate Professor in Neurology at Weill-Cornell Medical College, Institute of Academic Medicine, Houston Methodist, and Texas A&M College of Medicine and an Adjunct Associate Professor of Psychology, University of Houston. He is a Fellow of The National Academy of Neuropsychology and Sports Neuropsychology Society. He has lectured extensively on various aspects of sports-concussion assessment and treatment.  He has been involved tele-health delivery for concussion assessment care for over four years.

Dr. Cullum
is Professor of Psychiatry, Neurology, and Neurological Surgery at The University of Texas Southwestern Medical Center.  He holds the Pam Blumenthal Distinguished Professorship in Clinical Psychology, serves as Vice Chair and Chief of the Division of Psychology in the Department of Psychiatry, and is the Senior Neuropsychologist in the Peter O’Donnell Brain Institute at UT Southwestern.  He completed his PhD in Clinical Psychology at The University of Texas at Austin, followed by an internship and postdoctoral residency in clinical neuropsychology at UCSD and the San Diego VA.  Dr. Cullum’s research includes short and long term effects of concussion as well as risk factors and differential diagnosis of neurodegenerative conditions, as well as neuropsychological applications of telehealth technology.  He is the Scientific Director for the Texas Alzheimer’s Research and Care Consortium (TARCC), is a Past-President of the National Academy of Neuropsychology and the Society for Clinical Neuropsychology (APA Division 40), and is President-Elect of the Sports Neuropsychology Society.  

Dr. Gioia is the Division Chief of Pediatric Neuropsychology at Children’s National Health System, where he directs the SCORE Concussion Program. He is Professor of Pediatrics and Psychiatry at the GWU School of Medicine. He has developed a number of post-concussion tools for children, and worked with the CDC on their “Heads Up” concussion educational toolkits. Dr. Gioia has participated in the International Concussion in Sport Group Consensus meetings, American Academy of Neurology Sports Concussion Guideline panel, and the CDC’s mild TBI guideline development. He provided concussion management services to youth, high school, college and professional teams. He is the current President and Fellow of the Sports Neuropsychology Society.

NAN members login and non-members create an account to:




The Last Mile: Effectively Connecting Data & Analytics into a Population Health Care Model

1.0 CE Credit

 

Presented by:

Nirav N Vakharia, MD
Cleveland Clinic










There remains a gap between the promise of how big data, analytics, and IT solutions can improve the care of populations, and how they are currently used in the day-to-day work of care teams. Despite the abundance of data feeds from electronic health records, billing systems, payor claims, as well as publicly available data like census information, aggregated social determinants data, etc., relatively little information is used at the point of care to personalize the care of an individual or a group. The reasons for this are numerous and will be explored during this session, along with examination of best practices in which data have successfully been connected into a care model to drive outcomes and improve health.

After the session, participants will be able to:

1. Explain the differences among various types of data that can be integrated to determine population segmentation and risk stratification.
2. Identify the commonly encountered barriers to effective integration of data/analytics into medical decision making at the point of care.
3. Describe key factors from two successful examples of how the integration of big data at the point of care led to improved patient outcomes.

 

Target Audience: Neuropsychologists at all career levels

Instructional Level: Intermediate

Dr. Nirav Vakharia is a primary care physician at the Cleveland Clinic where he also serves as Vice Chief, Value Based Operations; President and Medical Director, Medicare Accountable Care Organization in the Community Care Unit.  In these roles he is supporting efforts to build the system’s capabilities to succeed in risk-based payment models, with a specific focus on enabling the population health strategy. He also co-leads a clinical process improvement training program that engages frontline clinicians in improvement efforts via experiential learning.  His current research projects include using public datasets to assess the cost of harm, and identification of factors that lead to preventable admissions.
Dr. Vakharia received his B.S in Biomedical Engineering from Case Western Reserve University and M.D. from Harvard Medical School. He completed training in internal medicine and a chief residency at the Brigham and Women's Hospital in Boston, MA. Before entering medicine, he worked as a middle school math and science teacher in an underserved public school in Washington, DC.


NAN members login and non-members create an account to:

Update on Health Care Policy: From Status to Advocacy

1.0 CE Credit

 

Presented by:

Antonio E. Puente, Ph.D.
Professor of Psychology
University of North Carolina Wilmington




 Despite a languishing congressional legislative climate, numerous legal and regulatory changes have occurred in 2018-2019 resulting in considerable paradigm shifts in the conceptualization and delivery of neuropsychological services. The foundational concepts will be presented as a means to understanding the reason for the majority of these changes. Pragmatic applications of these foundational concepts will then be described as a means to understand how the practice of neuropsychology is changing. A comparison of traditional and new models for the practice of clinical neuropsychology will be discussed. Limitations to this paradigm shift will be considered, with potential solutions outlined. Finally, the horizon of anticipated changes will be presented as a means to begin preparing for the new round of health care shifts.

 After the webinar, participants will be able to:

1. Describe the history and foundation for the practice of clinical neuropsychology.
2. Explain the basic reasons why the new testing codes occurred.
3. Discuss how the present situation is a paradigm shift not only for reimbursement but for the practice of clinical neuropsychology.

Target Audience: Psychologists interested in receiving updated information regarding APA reorganization, advocacy efforts, and changes to CPT codes. 

Instructional Level: Introductory

Antonio Puente, Ph.D., Professor of Psychology at the University of North Carolina Wilmington (UNCW), was the 2017 President of the American Psychological Association.  His research focuses on the interface between culture and neuropsychology and is the author/editor of eight books, 22 chapters, and 110 articles. He maintains a private practice in clinical neuropsychology, ranging from clinical to forensic assessments.  He was on the Editorial Panel of the American Medical Association’s Current Procedural Terminology.

NAN members login and non-members create an account to:



Wada (Intracarotid Amobarbital) Procedure: Clinical Applications 

1.5 CE Credits

Presented by:
Gregory P. Lee, Ph.D., ABPP-CN
Professor, Department of Neurology, School of Medicine
Professor, School of Allied Health Sciences and School of Graduate Studies
Georgia Health Sciences University

Wada testing is an established method to lateralize language and memory functions prior to epilepsy surgery in an attempt to prevent postoperative aphasia and memory loss.  Wada memory testing has also become useful in corroborating the side of seizure onset and assisting in the prediction of seizure-relief outcome.  This webinar will describe in detail the current most widely utilized Wada testing protocol for assessing language and memory after amobarbital administration as well as the related angiography procedures and how to analyze results and make surgical recommendations.  Discussion regarding potential confounding factors, such as angiographic cross-flow, fetal origin arteries, antiepileptic drugs that may reduce amobarbital potency, seizures during the procedure, and severe behavioral reactions will be reviewed.  The pros and cons of using drugs other than amobarbital will be briefly considered and the status of the Wada in light of the newer, less invasive procedures, such as functional MRI and magnetoencephalography will also be covered.  

After the webinar, participants will be able to:

  1. Describe the cognitive testing methods used to evaluate language and memory during the Wada procedure.
  2. Analyze common Wada test result patterns and apply them to surgical recommendations.
  3. List the major problems than can arise during the Wada and select procedures that help reduce their impact.
  4. List the medical diagnostic procedures that will most likely replace Wada testing eventually and describe their current shortcomings.  

Target Audience: Clinical neuropsychologists and students of neuropsychology (residents, interns, graduate students) who are interested in epilepsy surgery practice.

Instructional Level:
 Intermediate-to-Advanced

About Gregory P. Lee, Ph.D., ABPP-CN
 
Dr. Lee is a Professor of Neurology in the Medical College of Georgia at Georgia Regents University.  He is board-certified in Clinical Neuropsychology by ABPP/ABCN and a fellow of the American Psychological Association and the National Academy of Neuropsychology.  Dr. Lee is the Director of Adult Neuropsychological Services for the Departments of Neurology and Neurosurgery at the Medical College of Georgia, and he teaches courses in the behavioral neurosciences for medical, allied health, and neuroscience graduate students and neurology residents.  Professor Lee is also an active researcher with over 150 publications primarily in the areas of clinical epilepsy and epilepsy surgery, and author of the book, Neuropsychology of Epilepsy & Epilepsy Surgery, published by Oxford University Press.

NAN members login and non-members create an account to:

 

Writing Useful Neuropsychological Reports

2.0 CE Credit

 

Presented by:

Jacobus Donders, PhD, ABPP
Chief Psychologist
Mary Free Bed Rehabilitation Hospital




 





This seminar describes ways to improve the degree to which reports on neuropsychological assessments are useful to the consumer, whether that be a physician, a parent, a teacher, a judge, or another party.  Examples of application across the lifespan and in both clinical and forensic settings are provided.  Special attention is paid to the training of interns and residents in report writing, and how constructive supervision may make this process more effective.  

After the webinar, participants will be able to:
1. Discuss general guidelines for preparation of evidence-based and practically useful neuropsychological reports.
2. Apply specific guidelines for effective report writing in various clinical and forensic settings across the lifespan.
3. Use a Socratic method of supervision to help predoctoral and postdoctoral trainees develop better report writing skills.

Target Audience: Clinical and forensic neuropsychologists and neuropsychology trainees

Instructional Level:
Intermediate

Dr. Jacobus Donders is the Chief Psychologist at Mary Free Bed Rehabilitation Hospital in Grand Rapids, MI.  He is board-certified in Clinical Neuropsychology as well as Rehabilitation Psychology through the American Board of Professional Psychology.  In addition to being an active clinical practitioner, he has served on multiple editorial and executive boards, has authored or co-authored more than 100 publications in peer-reviewed journals, and has edited or co-edited six textbooks.  Dr. Donders is a current associate editor of the journals Child Neuropsychology and Archives of Clinical Neuropsychology.  He is completing his term as secretary of the American Board of Clinical Neuropsychology.  He is also a Fellow of the American Psychological Association and of the National Academy of Neuropsychology.

NAN members login and non-members create an account to: